Two years following US approval, Japan's Shionogi wins EU green light for opioid constipation drug

Two years following US approval, Japan's Shionogi wins EU green light for opioid constipation drug

Source: 
Endpoints
snippet: 

Nearly two years after winning US approval for its opioid-induced constipation drug, Japan’s Shionogi has secured the European nod for the treatment, naldemedine, in patients that have been previously treated with a laxative.